GEBT Telehealth Administration Usability Study - Trial NCT04684992
Access comprehensive clinical trial information for NCT04684992 through Pure Global AI's free database. This phase not specified trial is sponsored by Cairn Diagnostics and is currently Completed. The study focuses on Gastroparesis. Target enrollment is 36 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Cairn Diagnostics
Timeline & Enrollment
N/A
Dec 11, 2020
Mar 10, 2021
Primary Outcome
Patient Ability to Prepare and Administer the 13C-Spirulina GEBT, Under the Supervision of a Telehealth Professional, According to Instructions,Patient Ability to Prepare and Administer the 13C-Spirulina GEBT, Under the Supervision of a Telehealth Professional, According to Instructions,Patient Ability to Complete the GEBT Test Request Form, Under the Supervision of a Telehealth Professional, According to the Instructions,Patient Ability to Complete the GEBT Test Request Form, Under the Supervision of a Telehealth Professional, According to the Instructions,Patient Ability to Collect GEBT Breath Samples Under the Supervision of a Telehealth Professional,Ability to Successfully Ship Kits/Breath Samples to/From Home,Ability of a Telehealth Platform to Function Correctly,Ability of a Telehealth Platform to Function Correctly,Safety of Telehealth Administration of 13C-Spirulina GEBT Versus Administration in a Clinician's Facility
Summary
The purpose of this study is to establish the usability of a telehealth platform for the
 administration of GEBT.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04684992
Device Trial